Point of Care Diagnostics Market Size, Share, Growth & Industry Analysis, By Product Type (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy, Others), By Sample (Blood, Nasal, Urine, Others), By End-User (Hospital, Pharmacy, Home Care, Others) and Regional Analysis, 2024-2031

Point of Care Diagnostics Market Size

The global Point of Care Diagnostics Market size was valued at USD 47.64 billion in 2023 and is projected to reach USD 98.46 billion by 2031, growing at a CAGR of 9.53% from 2024 to 2031. Technological advancements, coupled with an increasing prevalence of infectious diseases, are driving the demand for point-of-care diagnostic devices.

In the scope of work, the report includes products offered by companies such as Abbott, Hoffmann-La Roche Ltd., HemoCue, Siemens Healthineers AG, Johnson & Johnson Services, Inc., BD, Bio-Rad Laboratories, Inc., Werfen, Thermo Fisher Scientific Inc., Sysmex Europe SE, and others.

The global point-of-care diagnostics market is experiencing robust growth fueled by rapid product developments and innovation. With the rise of infectious diseases such as HIV, tuberculosis, and malaria, among others, there is an increasing need for rapid and accurate diagnostic solutions to enable timely treatment and disease management.

Additionally, the emergence of COVID-19 accelerated the adoption of point of care diagnostics, highlighting the importance of decentralized testing in controlling disease spread. Moreover, the expansion of home healthcare, along with the aging population, is contributing to market growth. However, challenges such as reimbursement issues, counterfeit products, and competition from traditional diagnostic methods are impacting the growth of the market.

Despite facing challenges, the global point of care diagnostics market is poised to witness significant expansion in the forthcoming years, driven by technological advancements, increasing healthcare burden, and supportive regulatory frameworks. The global point-of-care diagnostics market encompasses the manufacturing, distribution, and utilization of diagnostic devices and tools designed to provide rapid and convenient testing at or near the point of patient care.

These diagnostics include a wide range of devices, from handheld analyzers to rapid tests, enabling healthcare professionals and individuals to quickly assess various health conditions without the need for extensive laboratory infrastructure. The market serves diverse applications, including infectious disease testing, chronic disease management, pregnancy testing, and drug screening.

Analyst’s Review 

The market is projected to experience substantial growth over 2024-2031 due to increasing emphasis on chronic diseases, expansion of the healthcare industry, and the rising need for rapid diagnostic tests.

Strategic imperatives such as mergers and acquisitions, product innovations, and collaborations with research institutions are projected to support market growth over the forecast period. Furthermore, partnerships with healthcare providers and regulatory agencies to expand market access and ensure compliance are anticipated to emerge as pivotal strategies in driving market growth.

Point of Care Diagnostics Market Growth Factors

The rising prevalence of infectious diseases worldwide is fueling the demand for rapid and accurate diagnostic solutions, thereby driving market growth. According to the Centers for Disease Control and Prevention (CDC), infectious diseases remain a significant cause of morbidity and mortality globally, with emerging infectious diseases posing ongoing challenges to public health.

Point of care diagnostics play a crucial role in the timely detection and management of infectious diseases such as HIV, tuberculosis, and malaria, particularly in resource-limited settings where access to laboratory infrastructure is restricted.

• For instance, rapid antigen tests and molecular diagnostics have been instrumental in the detection of COVID-19, enabling prompt isolation and treatment of infected individuals.

Furthermore, advanced diagnostic platforms, such as handheld analyzers and smartphone-based testing devices, are gaining traction due to their characteristics such as portability, ease of use, and ability to deliver rapid results.

• For instance, companies such as F. Hoffmann-La Roche have introduced next-generation diagnostic platforms, such as the Cobas-h 232 POC system, capable of providing results in less than 20 minutes.

Furthermore, the integration of technologies such as artificial intelligence and microfluidics is enhancing the sensitivity and accuracy of point-of-care diagnostic devices, thereby driving their adoption across diverse healthcare settings.

Despite the significant growth, the market faces major challenges such as inadequate standardization compared to centralized laboratory methods. The lack of uniformity in testing protocols and quality control measures across different point-of-care devices can lead to variability in results and affect diagnostic accuracy.

Key industry players are increasingly focusing on developing standardized testing protocols and quality assurance measures for point-of-care diagnostics to overcome such challenges. Furthermore, collaborations between companies, regulatory agencies, and professional organizations facilitate the establishment of guidelines and standards to ensure consistency and reliability across point-of-care testing platforms.

Point of Care Diagnostics Market Trends

The rising integration of technology in point-of-care diagnostics is fostering market growth. Advanced technologies such as biosensors, microfluidics, and nanotechnology are enhancing diagnostic performance significantly. These innovations are leading to increased accuracy and sensitivity in disease detection, thereby ensuring more reliable test results with minimal sample volumes.

Moreover, the integration of advanced microfluidic designs and functionalities is facilitating faster turnaround times for diagnoses, thus enabling prompt medical interventions. Additionally, the multichannel functionality of certain point-of-care devices offers simultaneous testing for multiple parameters on a single sample, thereby saving both time and resources.

This trend signifies the improvement of patient care by facilitating timely and accurate diagnoses while enhancing operational efficiency within healthcare settings. As technology continues to evolve, further advancements in point-of-care diagnostics are expected to facilitate continuous improvement in performance and capabilities.

Moreover, the growing utilization of connected POC devices and the transmission of data to healthcare providers or cloud platforms is enhancing data management and connectivity. It enables remote monitoring, providing clinics with access to patient test results remotely, leading to better care coordination and timely interventions.

Furthermore, cloud-based platforms are facilitating the process of data aggregation and analysis, thereby providing valuable insights into disease trends and treatment effectiveness, which is improving healthcare decision-making. Additionally, the integration of connected POC devices with telehealth platforms enables virtual consultations based on diagnostic results, thus enhancing patient access to care and promoting the adoption of telehealth practices.

Segmentation Analysis

The global point of care diagnostics market is segmented based on product type, sample, end-user, and geography.

By Product Type

Based on product type, the point of care diagnostics market is categorized into glucose, HIV, Hep-C, HPV, hematology, pregnancy, and others. The glucose segment captured the largest market share of 31.87% in 2023. Diabetes mellitus represents a significant global health concern, with an increasing prevalence worldwide.

• According to the International Diabetes Federation, over 460 million adults between the age of 20-79 years had diabetes in 2023, and this number is expected to rise to 700 million by 2045.

As glucose testing is a fundamental component of diabetes management, the demand for point-of-care glucose testing devices is likely to continue to grow over the forecast period.

Furthermore, the advent of advanced glucose monitoring technologies, such as continuous glucose monitoring (CGM) systems and non-invasive glucose monitoring devices, has expanded the scope of the application of glucose testing in point of care settings. These technologies offer patients greater convenience, accuracy, and real-time monitoring capabilities, thereby driving adoption rates.

By Sample

Based on sample, the point of care diagnostics market is classified into blood, nasal, urine, and others. The blood segment garnered the highest revenue of USD 24.91 billion in 2023. The prevalence of blood as the most commonly utilized and dependable type of sample for diagnostic testing across a wide spectrum of medical conditions is driving the growth of the segment.

Blood samples allow for the detection of various biomarkers, including proteins, enzymes, antibodies, and genetic material, providing comprehensive insights into an individual's health status. Furthermore, blood-based diagnostic tests are widely adopted in clinical practice due to their accuracy, sensitivity, and specificity. Point-of-care blood testing devices offer rapid results, enabling timely diagnosis and treatment decisions, particularly in emergency and critical care settings.

By End-User

Based on end-user, the point of care diagnostics market is divided into hospital, pharmacy, home care, and others. The home care segment is anticipated to witness the fastest growth at a CAGR of 10.33% over the forecast period. The rising trend toward home-based healthcare solutions, mainly driven by demographic shifts, technological advancements, and changing patient preferences, is propelling the demand for home care diagnostics.

The growing geriatric population, coupled with the rising prevalence of chronic diseases, is creating a greater demand for convenient and accessible healthcare options that allow individuals to monitor their health conditions from the comfort of their homes.

Moreover, advancements in point-of-care diagnostic technologies have made it increasingly feasible to perform complex diagnostic tests outside traditional laboratory settings. Portable and user-friendly diagnostic devices enable patients to conduct self-tests and monitor their health parameters, thereby empowering them to take a more active role in their healthcare management.

Point of Care Diagnostics Market Regional Analysis

Based on region, the global point of care diagnostics market is classified into North America, Europe, Asia-Pacific, MEA, and Latin America.

The North America Point of Care Diagnostics Market share stood around 32.86% in 2023 in the global market, with a valuation of USD 15.64 billion. The region boasts a well-established healthcare infrastructure, with advanced healthcare facilities, robust regulatory frameworks, and substantial healthcare expenditure, thereby supporting regional market growth. Additionally, the region is at the forefront of technological innovation, with a strong focus on research and development in healthcare diagnostics.

Furthermore, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is driving the demand for point-of-care diagnostic solutions in North America.

Moreover, the region's proactive approach toward early disease detection and prevention, coupled with increasing awareness regarding the importance of timely diagnosis, is fueling market growth. The presence of key market players and strategic initiatives, such as partnerships, mergers, and acquisitions, further contribute to North America's dominance in the global point-of-care diagnostics market.

Asia-Pacific is poised to register a robust CAGR of 10.32% through the forecast period. The region encompasses a rising prevalence of chronic diseases and infectious illnesses, which is driving the demand for rapid and accessible diagnostic solutions. Moreover, increasing healthcare expenditure, improving healthcare infrastructure, and expanding access to healthcare services in countries such as China, India, and Japan, are fueling regional market growth.

Additionally, technological advancements and the growing adoption of point-of-care diagnostics in both urban and rural healthcare settings boost market penetration. Furthermore, supportive government initiatives aimed at improving healthcare accessibility and affordability, along with the growing focus on preventive healthcare, are stimulating regional market expansion.

Key market players are increasingly investing to capitalize on emerging opportunities and address unmet healthcare needs in this region, thereby contributing to the region's robust growth in the point-of-care diagnostics market.

Competitive Landscape

The global point of care diagnostics market report will provide valuable insight with an emphasis on the fragmented nature of the industry. Prominent players are focusing on several key business strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their market shares across different regions.

Strategic initiatives, including investments in R&D activities, the establishment of new manufacturing facilities, and supply chain optimization, are foreseen to create new opportunities for market growth. The key players in the market are

List of Key Companies in Point of Care Diagnostics Market

• Abbott
• Hoffmann-La Roche Ltd.
• HemoCue
• Siemens Healthineers AG
• Johnson & Johnson Services, Inc.
• BD
• Bio-Rad Laboratories, Inc.
• Werfen
• Thermo Fisher Scientific Inc.
• Sysmex Europe SE

The Global Point of Care Diagnostics Market is Segmented as:

By Product Type

• Glucose
• HIV
• Hep C
• HPV
• Hematology
• Pregnancy
• Others

By Sample

• Blood
• Nasal
• Urine
• Others

By End-User

• Hospital
• Pharmacy
• Home Care
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • U.K.
  • Spain
  • Germany
  • Italy
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Middle East & Africa
  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America